Home LiteratureArticle Details
PMID: 16575950 Published · ppublish English Comment Letter

Infliximab for ulcerative colitis.

The New England journal of medicine ·Vol. 354 ·No. 13 ·2006-03-30 ·Pages 1424-6; author reply 1424-6

Becker JM, Prushik SG, Stucchi AF

Abstract

暂无摘要

MeSH Terms
Antibodies, Monoclonal/adverse effects,therapeutic use Colitis, Ulcerative/therapy Colonic Pouches/adverse effects Humans Infliximab Pouchitis/epidemiology,etiology Treatment Failure Tumor Necrosis Factor-alpha/antagonists & inhibitors
Chemicals
Antibodies, Monoclonal Tumor Necrosis Factor-alpha Infliximab
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Becker James M
Prushik Scott G
Stucchi Arthur F
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
Published
2006-03-30
Pages
1424-6; author reply 1424-6
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Corrections
CommentOn
PMID: 16339095
External Links
PubMed source View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2